You have 9 free searches left this month | for more free features.

Famotidine tablets fed study

Showing 26 - 50 of 5,573

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Trial in Darmstadt (Test Glucophage® XR, Reference Glucophage® XR)

Recruiting
  • Healthy
  • Test Glucophage® XR
  • Reference Glucophage® XR
  • Darmstadt, Germany
    Research Site
Aug 10, 2022

Healthy Trial in Christchurch (SP-104, Naltrexone Hydrochloride 50Mg Oral Tablet)

Completed
  • Healthy
  • SP-104
  • Naltrexone Hydrochloride 50Mg Oral Tablet
  • Christchurch, New Zealand
    Christchurch Clinical Studies Trust (NZCR)
Apr 29, 2022

Healthy Volunteers Trial in Qingdao (Dotilavir sodium tablet, Dotilavir sodium tablet(Tivicay@))

Recruiting
  • Healthy Volunteers
  • Dotilavir sodium tablet
  • Dotilavir sodium tablet(Tivicay@)
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University
Dec 8, 2021

Healthy Trial in Cairo (Gleptomet 50/1000(Metformin HCl & Sitagliptin), Janumet 50/1000(Metformin HCl & Sitagliptin))

Completed
  • Healthy
  • Gleptomet 50/1000(Metformin HCl & Sitagliptin)
  • Janumet 50/1000(Metformin HCl & Sitagliptin)
  • Cairo, Egypt
    Genuine Research Center GRC
Mar 22, 2023

HIV-1-infection Trial in Montréal (abacavir, dolutegravir and lamivudine dispersible tablets, Triumeq Dispersible Tablets 5 mg

Completed
  • HIV-1-infection
  • abacavir, dolutegravir and lamivudine dispersible tablets
  • Triumeq Dispersible Tablets 5 mg GSK1349572 [Dolutegravir]/ 60 mg Abacavir/ 30 mg Lamivudine
  • Montréal, Quebec, Canada
    Altasciences
Mar 10, 2022

Healthy Subjects Trial in Toronto (Dapagliflozin 10 mg tablets, Farxiga® 10 mg tablets)

Completed
  • Healthy Subjects
  • Dapagliflozin 10 mg tablets
  • Farxiga® 10 mg tablets
  • Toronto, Ontario, Canada
    Pharma Medica Research Inc.
May 6, 2021

Healthy Participants Trial in Miami, Austin (Deucravacitinib, Famotidine)

Completed
  • Healthy Participants
  • Miami, Florida
  • +1 more
Feb 24, 2022

Healthy Trial in Daejeon (Glucophage® XR Test, Glucophage® XR Reference)

Completed
  • Healthy
  • Glucophage® XR Test
  • Glucophage® XR Reference
  • Daejeon, Korea, Republic of
    Clinical Trials Center, Chungnam National University Hospital
Mar 30, 2022

Pharmacokinetics Trial in Mönchengladbach (Vericiguat(BAY1021189, high-dose pediatric-formulation)_fed, Vericiguat(BAY1021189,

Completed
  • Pharmacokinetics
  • Vericiguat(BAY1021189, high-dose pediatric-formulation)_fed
  • +5 more
  • Mönchengladbach, Nordrhein-Westfalen, Germany
    CRS Clinical-Research-Services Mönchengladbach GmbH
Dec 9, 2021

Healthy Participants Trial in Miami (Atazanavir, Cobicistat, Atazanavir/Cobicistat Mini-tablet)

Completed
  • Healthy Participants
  • Miami, Florida
    Local Institution - 0001
Oct 27, 2022

Bioequivalence Trial in Yaroslavl (Rivaroxaban film-coated tablet 20 mg, Xarelto® film-coated tablet 20 mg)

Unknown status
  • Bioequivalence
  • Rivaroxaban film-coated tablet 20 mg
  • Xarelto® film-coated tablet 20 mg
  • Yaroslavl, Russian Federation
    Private healthcare institution "Clinical Hospital "RZD-Medicine"
Jan 25, 2021

Antifungal Agents Trial in Navi Mumbai (Griseofulvin 500 mg, Griseofulvin 250 mg, Reference Griseofulvin 500 mg)

Completed
  • Antifungal Agents
  • Griseofulvin 500 mg
  • +2 more
  • Navi Mumbai, India
    GSK Investigational Site
Dec 1, 2020

Myeloma Multiple Trial in Chia (Dasatinib 100 MG)

Not yet recruiting
  • Myeloma Multiple
  • Dasatinib 100 MG
  • Chia, Cundinamarca, Colombia
    CAIMED
Jul 12, 2023

Lupus Trial in Nottingham (BMS-986165-01, BMS-986165 Tablet, Famotidine)

Completed
  • Lupus
  • Nottingham, United Kingdom
    Quotient Sciences
Jan 5, 2021

Emergent Prep for IV Dye in Acute Stroke Patients With Allergy

Enrolling by invitation
  • Stroke
  • Dye Allergy
  • Emergent IV Dye Preparation
  • Philadelphia, Pennsylvania
    (unnamed)
Jun 7, 2023

2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease Trial (Famotidine, Celecoxib, Placebo)

Not yet recruiting
  • 2019 Novel Coronavirus Disease
  • +11 more
  • (no location specified)
Aug 15, 2022

Healthy Trial in Biberach (EU-sourced Otezla® (T), US-sourced Otezla® (R1), Japan-sourced Otezla® (R2))

Terminated
  • Healthy
  • EU-sourced Otezla® (T)
  • +2 more
  • Biberach, Germany
    Humanpharmakologisches Zentrum Biberach
Aug 31, 2021

Parkinson Disease Trial in Ahmedabad (WD-1603 CARBIDOPA/LEVODOPA EXTENDED-RELEASE TABLETS)

Unknown status
  • Parkinson Disease
  • WD-1603 CARBIDOPA/LEVODOPA EXTENDED-RELEASE TABLETS
  • Ahmedabad, India
    Lambda Therapeutic Research Ltd.
Oct 11, 2020

2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease Trial in United States (Famotidine,

Terminated
  • 2019 Novel Coronavirus Disease
  • +11 more
  • Newport Beach, California
  • +14 more
Jul 20, 2022

Healthy Trial in Jeonju (Janumet XR tablet 100/1000 mg, GLH1SM tablet 100/1000 mg)

Completed
  • Healthy
  • Janumet XR tablet 100/1000 mg
  • GLH1SM tablet 100/1000 mg
  • Jeonju, Jeollabuk-do, Korea, Republic of
    Chonbuk National University Hospital
Jul 21, 2020

Healthy Volunteers Trial in Grayslake (Venetoclax)

Recruiting
  • Healthy Volunteers
  • Grayslake, Illinois
    Acpru /Id# 259897
Oct 2, 2023

Healthy Volunteers Trial in Brooklyn (AZD5055 solution for infusion, AZD5055 oral suspension, AZD5055 film-coated tablet)

Recruiting
  • Healthy Volunteers
  • AZD5055 solution for infusion
  • +3 more
  • Brooklyn, Maryland
    Research Site
Dec 15, 2022

Parkinson Disease Trial in Ahmedabad (WD-1603 CARBIDOPA and LEVODOPA EXTENDED-RELEASE TABLETS)

Recruiting
  • Parkinson Disease
  • WD-1603 CARBIDOPA and LEVODOPA EXTENDED-RELEASE TABLETS
  • Ahmedabad, India
    Lambda Therapeutic Research Ltd.
Sep 9, 2020

Healthy Trial in ChangSha (Loratadine (Xisimin [Test Treatment]), Loratadine (Clarityne [Reference Treatment]))

Completed
  • Healthy
  • Loratadine (Xisimin [Test Treatment])
  • Loratadine (Clarityne [Reference Treatment])
  • ChangSha, China
    Xiangya Hospital Central South University
May 12, 2020